It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
A shaman may be initiated via a serious illness, by being struck by lightning and dreaming of thunder to become a Heyoka, or by a near-death experience (e.g., the shaman Black Elk), or one might follow a "calling" to become a shaman. There is usually a set of cultural imagery expected to be experienced during shamanic initiation regardless of the method of induction. According to Mircea Eliade, such imagery often includes being transported to the spirit world and interacting with beings inhabiting the distant world of spirits, meeting a spiritual guide, being devoured by some being and emerging transformed, and/or being "dismantled" and "reassembled" again, often with implanted amulets such as magical crystals. The imagery of initiation generally speaks of transformation and the granting powers to transcend death and rebirth.
Shamanic illness
Shamanic illness, also called shamanistic inititatory crisis, is a psycho-spiritual crisis, usually involuntary, or a rite of passage, observed among those becoming shaman. The episode often marks the beginning of a time-limited episode of confusion or disturbing behavior where the shamanic initiate might sing or dance in an unconventional fashion, or have an experience of being "disturbed by spirits". The symptoms are usually not considered to be signs of mental illness by interpreters in the shamanic culture; rather, they are interpreted as introductory signposts for the individual who is meant to take the office of shaman (Lukoff et.al, 1992). Similarities of some shamanic illness symptoms to the kundalini process have been often noted. The significant role of initiatory illnesses in the calling of a shaman can be found in the detailed case history of Chuonnasuan, the last master shaman among the Tungus peoples in Northeast China.
Some UFO researchers argue that there is a broad, fairly consistent sequence and description of events which make up the typical "close encounter of the fourth kind" (a popular but unofficial designation building on Dr. J. Allen Hynek's classifying terminology). Though the features outlined below are often reported, there is some disagreement as to exactly how often they actually occur. Some researchers (especially Budd Hopkins and David Michael Jacobs) have been accused of excluding, minimising or suppressing testimony or data which do not fit a certain paradigm for the phenomenon.
Bullard argues most abduction accounts feature the following events. They generally follow the sequence noted below, though not all abductions feature all the events:
Capture. The abductee is forcibly taken from terrestrial surroundings to an apparent alien space craft.
Examination. Invasive medical or scientific procedures are performed on the abductee.
Conference. The abductors speak to the abductee.
Tour. The abductees are given a tour of their captors' vessel.
Loss of Time. Abductees rapidly forget the majority of their experience.
Return. The abductees are returned to earth. Occasionally in a different location from where they were allegedly taken or with new injuries or disheveled clothing.
Theophany. The abductee has a profound mystical experience, accompanied by a feeling of oneness with God or the universe.
Aftermath. The abductee must cope with the psychological, physical, and social effects of the experience.
'___' and Psilocybin Research
From a MAPS publication about hallucinogen research.
Dr. Rick Strassman
University of New Mexico Medical School
The National Institute on Drug Abuse (NIDA) has scored highly a grant proposal to continue the clinical research with hallucinogens we have been performing since November, 1990. In all likelihood, funding will begin either late this year or early next. The grant proposal is for three additional years of projects, and the total award is for approximately $500,000. The grant will support three '___' studies, and one psilocybin study.Two of the '___' studies involve attempts to modify '___''s biological and psychological effects by pre-treating subjects with drugs believed to have an effect on brain areas affected by '___'. '___''s effects, like those of other "classical hallucinogens" such as '___', psilocybin, and mescaline, are probably caused by an interaction with certain nerve cells contained within the brain. These cells are part of the serotonin system. Serotonin is a chemical, a neurotransmitter, which allows nerve cells to communicate with each other across tiny spaces, called "synapses." A serotonin-containing nerve cell which is stimulated beyond a certain threshold "fires," releasing serotonin into the synapse, which then attaches to specialized sites on the "receiving" nerve cell called "receptors." Serotonin attaches to its receptors, thus modifying the electrical activity of the receiving cell, which in turn either fires itself, or is prevented from firing. There are several varieties of serotonin receptors, called "subtypes," including the type "1A," "1B," "1C," "1D," "1E,""2," "3," and "4." Psychedelics are most strongly bound to the 1A, 1C, and 2 subtypes.
Drugs which block serotonin-2, -1C, and -1A subtypes have been found to block the effects of hallucinogens in lower animals. However, tests of "hallucinogenicity" in lower animals are open to criticism because of the difficulty in knowing exactly what the animal is responding to. Clearly, human studies are necessary to refute, confirm, or modify existing hypotheses generated by lower animals experiments. Thus, we are interesting in determine which serotonin receptors, in man, mediate specific effects of '___'.
Our original '___' study demonstrated that '___' raised blood levels of beta- endorphin, cortisol, adrenal stimulating hormone, and prolactin; all of these hormones' regulation is believed controlled, to some extent, by serotonin receptors in the brain. In addition, we found rises in blood pressure, heart rate, pupil diameter, and core temperature in response to '___'; these variables also are regulated to some extent by serotonin nerve cells. Finally, we have carefully mapped out the psychological effects of '___' using the Hallucinogen Rating Scale, the development of which was discussed in a previous article. Now that we have this data describing effects of '___' by itself, we can pre-treat subjects with drugs that block certain types of serotonin receptors, and see what happens to these factors. For example, if pre-treatment with a serotonin-1A blocking drug enhances visual effects, but reduces beta-endorphin stimulation, we can suggest that the serotonin-1A receptor mediates those functions. These data could have use in developing antidotes for certain problematic reactions to psychedelics, and provide insights into important brain-mind interactions. They also might provide glimpses of understanding into spontaneous "psychedelic" states, such as some naturally occurring psychotic phenomena.
We have found a likely candidate for a serotonin-1A blocking drug, our first blockade project. However, we have been unsuccessful in locating a serotonin-2 and serotonin-1C drug, the second series of studies. These two latter receptors are extremely similar, and drugs that block the "2" subtype usually block the "1C" as well. There are several "2/1C" agents at various stages of development within human and animal studies, but so far, no one has agreed to provide such a drug to us. Efforts are continuing.The last '___' study is an attempt to develop tolerance to repeated administrations of '___' at one sitting. All other psychedelics, in man, have demonstrated tolerance to repeated administration. Thus, '___' at the same dose every day for three days, prevents that originally active dose from having any effect on the fourth consecutive day. Several days drug-free are necessary to return to the previous level of sensitivity. '___', administered twice a day (10 a.m. and 3 p.m.) for five days, in the only published human study that attempted to develop tolerance, demonstrated no tolerance. Animal studies have also given inconsistent results, with one study giving it every 2 hours for 21 days and finding only limited tolerance! Some animal studies have even suggested that sensitivity is increased depending on the timing and dose schedule. Finally, humans tolerant to '___' are not tolerant to '___'. Reports "from the field" are also not consistent. If any of you reading this have experience with repeated administration of '___', I would be most interested in hearing about them.
The importance of developing (or not developing) tolerance to '___' derives from at least two perspectives. One is the fact that the inability to generate tolerance to '___' in humans is one of '___''s strongest characteristics suggesting its role in spontaneous psychotic states. Recall that the discovery of '___' in human body fluids set off a flurry of investigations assessing whether it was involved in psychoses. If '___' does have a role in spontaneous hallucinations, and it were possible to develop tolerance to its effects with repeated and/or continuous exposure, then people would only hallucinate when tolerance was no longer in effect. However, that is contrary to clinical experience, inasmuch as people with psychotic illness often hallucinate continuously. Therefore, if we cannot develop tolerance, a role for '___' in mental illness would be supported. Secondly, the "tolerant state" is of great interest in the field of psychopharmacology. Why drugs "no longer work" when they used to is of practical importance in treatment of mental illness, understanding how psychoactive drugs (including alcohol, nicotine, coc aine, '___', and others) work. Particularly with respect to hallucinogens, how a previously psychedelic dose of '___' could have no effect in someone with repeated exposure to the drug is a fascinating question for mind-brain researchers.
Originally posted by Trojan_libido
If there is a global conciousness, a Godhead if you like, then it must be emminating from the body in exactly the same form regardless of whose body. I dont belive in E.T.s at all, so your question isn't really valid.
I believe if, whilst in the experience, you are presented with 'greys' or animal-human 'hybrids', then the experience must have something to do with our conciousness and/or DNA.
But my point is still valid, so what?
Originally posted by Trojan_libido
The correlation between UFO abductions and Shamanic experiences is detailed in a book called 'Supernatural', but I have experiences myself that brought me to the book in the first place.
I guess you need to have insight into some pseudo hallucinogens before you can even comprehend the power of '___' and its true hallucinations. Because this is endogenous in the body, and because of its effects, it should be more thoroughly investigated by a wider range of scientists. Unfortunately, because of fear and politics experiments with these substances are few and far between.
I'd love to hear about actual abductions, especially involving implants, but this is not really the environment for people posting anonymous truth.
Originally posted by mwall614
I agree, there is definitely a link between shamanism and abductions, I believe shamans visit other dimensions and aliens are actually from other dimensions so this theory makes a lot of sense to me.